the second line activity of sulphamethoxazole , in the form of cotrimoxazole ( ctz ) , has been investigated by treatment of 13 patients with ra for 24 weeks with ctz ( 480 mg three times a day ) .
C0038689
sulphamethoxazole
C0041044
ctz